FLEX Vascular Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 3

FLEX Vascular General Information

Description

Developer of endovascular devices designed to treat stenoses in arteriovenous fistulas and grafts and in peripheral vascular disease. The company offers devices that create controlled micro-incisions of any length in complex lesions of varying morphology to modify plaque and stenosis, providing acute luminal gain, improved vessel compliance, and consistent revascularization outcomes, enabling healthcare providers to prepare vessels in a simple, quick, and cost-effective way.

Contact Information

Formerly Known As
VentureMed Group
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2800 Campus Drive
  • Suite 50
  • Plymouth, MN 55441
  • United States
+1 (763)
Primary Industry
Surgical Devices
Other Industries
Drug Delivery
Corporate Office
  • 2800 Campus Drive
  • Suite 50
  • Plymouth, MN 55441
  • United States
+1 (763)

FLEX Vascular Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FLEX Vascular Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 17-Apr-2026 Completed Generating Revenue
5. Later Stage VC (Series C) 29-Oct-2025 Completed Generating Revenue
4. Later Stage VC (Series B) 11-Jul-2017 Completed Generating Revenue
3. Early Stage VC (Series A) 11-Dec-2014 Completed Generating Revenue
2. Accelerator/Incubator 24-Nov-2014 $1M $3M Completed Generating Revenue
1. Seed Round 01-Oct-2012 $2M $2M Completed Generating Revenue
To view FLEX Vascular’s complete valuation and funding history, request access »

FLEX Vascular Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C-1
Series C
Series B 62,329 $0.000100 $3.3 $206.24 $206.24 1x $9.03 21.36%
Series A 7,065 $0.000100 $4.19 $262.06 $262.06 1x $9.03 3.08%
To view FLEX Vascular’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

FLEX Vascular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of endovascular devices designed to treat stenoses in arteriovenous fistulas and grafts and in peripheral vasc
Surgical Devices
Plymouth, MN
23 As of 2025

Milpitas, CA
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FLEX Vascular Competitors (11)

One of FLEX Vascular’s 11 competitors is Elixir Medical, a Venture Capital-Backed company based in Milpitas, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Elixir Medical Venture Capital-Backed Milpitas, CA
Arsenal Medical Venture Capital-Backed Waltham, MA
Spine Wave Venture Capital-Backed Shelton, CT
Wallaby Medical Venture Capital-Backed Shanghai, China
ShockWave Medical Formerly VC-backed Santa Clara, CA
You’re viewing 5 of 11 competitors. Get the full list »

FLEX Vascular Patents

FLEX Vascular Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260130688-A1 Intravascular catheter having an dual, offset expandable incising portion, related systems and methods Pending 12-Aug-2022
AU-2023214268-A1 Intravascular catheter having an expandable incising portion and embolic protection device Active 12-Aug-2022
AU-2023214268-B2 Intravascular catheter having an expandable incising portion and embolic protection device Active 12-Aug-2022
EP-4321113-A1 Intravascular catheter having an expandable incising portion and embolic protection device Active 12-Aug-2022
EP-4321113-B1 Intravascular catheter having an expandable incising portion and embolic protection device Active 12-Aug-2022 A61B17/22031
To view FLEX Vascular’s complete patent history, request access »

FLEX Vascular Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FLEX Vascular Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
S3 Ventures Venture Capital Minority
Endeavour Vision Venture Capital Minority
RiverVest Venture Partners Venture Capital Minority
To view FLEX Vascular’s complete investors history, request access »

FLEX Vascular FAQs

  • When was FLEX Vascular founded?

    FLEX Vascular was founded in 2012.

  • Where is FLEX Vascular headquartered?

    FLEX Vascular is headquartered in Plymouth, MN.

  • What is the size of FLEX Vascular?

    FLEX Vascular has 23 total employees.

  • What industry is FLEX Vascular in?

    FLEX Vascular’s primary industry is Surgical Devices.

  • Is FLEX Vascular a private or public company?

    FLEX Vascular is a Private company.

  • What is FLEX Vascular’s current revenue?

    The current revenue for FLEX Vascular is .

  • How much funding has FLEX Vascular raised over time?

    FLEX Vascular has raised $72M.

  • Who are FLEX Vascular’s investors?

    S3 Ventures, Endeavour Vision, and RiverVest Venture Partners have invested in FLEX Vascular.

  • Who are FLEX Vascular’s competitors?

    Elixir Medical, Arsenal Medical, Spine Wave, Wallaby Medical, and ShockWave Medical are some of the 11 competitors of FLEX Vascular.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process